REPORT OF THE FIRST FRENCH ANTICARDIOLIPIN ANTIBODIES STANDARDIZATION WORKSHOP

被引:0
|
作者
ABUAF, N
MEYER, O
LAPERCHE, S
PIERRON, D
LAROCHE, P
RAJOELY, B
ROUQUETTE, AM
机构
[1] HOP BICHAT,FAC XAVIER BICHAT,RHUMATOL CLIN,F-75018 PARIS,FRANCE
[2] BMD,F-77423 MARNE LA VALLEE 2,FRANCE
[3] CHU ST ANTOINE,HOP TENON,SERV HEMATOL & IMMUNOL BIOL,F-75020 PARIS,FRANCE
关键词
STANDARDS; ELISA; AUTOANTIBODY; CARDIOLIPIN;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Anticardiolipine antibodies are a marker of the antiphospholipid syndrome. They are detected by Elisa. Despite its simplicity, the results obtained by this assay are not always reproducible despite several worldwide standardizations and the distribution of calibration sera by EN Harris. On 4 Decembre 1992, the First French Anticardiolipin Antibodies Standardization Workshop was held in Paris. Eight coded standards weve sent to 33 laboratories in France, one in Switzerland and one in Luxembourg. Some of them used several assays. Agreement between qualitative results was goad for samples with high and moderate level of antibodies. But the results expressed in IgC antiphospholipid units were scattered, the interlaboratory coefficient of variation for each of the eight standards was higher than 70%, though the within-run coefficient of variation had a median value of 10%. Assays using bovine serum for the blocking buffer and for the dilution buffer seemed to give more reproducible results than assays using purified bovine serum albumin (p < 0.001). For only nine assays out of 38 which expressed results quantitatively, was a linear regression observed between the dilutions of a sample and the results expressed in IgG antiphospholipid units. Absence of linearity is an obstacle which must be overcome if we wish to compare quantitative results obtained by different laboratories.
引用
收藏
页码:365 / 373
页数:9
相关论文
共 50 条
  • [21] ANTICARDIOLIPIN ANTIBODIES AND THROMBOSIS
    BICK, RL
    BAKER, WF
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (06) : 1287 - 1299
  • [22] Detection of anticardiolipin antibodies
    Dean, GS
    Isenberg, DA
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (02) : 258 - 259
  • [23] ANTICARDIOLIPIN ANTIBODIES IN UVEITIS
    KLOK, AM
    GEERTZEN, R
    ROTHOVA, A
    BAARSMA, GS
    KIJLSTRA, A
    CURRENT EYE RESEARCH, 1992, 11 : 209 - 213
  • [24] Anticardiolipin antibodies: To be or not to be detectable
    Tincani, A
    Meroni, PL
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2001, 19 (03) : 240 - 241
  • [25] Anticardiolipin antibodies in dogs
    Papini, R
    Pellegrini, O
    Rossini, C
    Guidi, G
    VETERINARY RESEARCH COMMUNICATIONS, 2004, 28 (01) : 355 - 357
  • [26] ANTICARDIOLIPIN ANTIBODIES AND PREECLAMPSIA
    SCOTT, RAH
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (06): : 604 - 605
  • [27] ANTICARDIOLIPIN ANTIBODIES AND HYPERCOAGULABILITY
    HESS, DC
    ANNALS OF INTERNAL MEDICINE, 1993, 118 (12) : 986 - 986
  • [28] ANTICARDIOLIPIN ANTIBODIES IN ECLAMPSIA
    RAO, AA
    ANANTHAKRISHNA, NC
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1992, 38 (01) : 37 - 40
  • [29] Revisiting the anticardiolipin test and its standardization
    Harris, EN
    Pierangeli, SS
    LUPUS, 2002, 11 (05) : 269 - 275
  • [30] PROBLEMS WITH THE STANDARDIZATION OF A ROUTINE ANTICARDIOLIPIN ASSAY
    MALIA, RG
    COOPER, SM
    PRESTON, FE
    GREAVES, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1988, 6 (02) : 207 - 207